Barbara Borroni
Overview
Explore the profile of Barbara Borroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
438
Citations
10761
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khasayeva N, Eierud C, Jensen K, Premi E, Borroni B, Calhoun V, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2025 Mar;
2024:1-4.
PMID: 40039485
This study investigates Alzheimer's Disease (AD) dementia through [18F]Florbetapir ([18F]FBP) Positron Emission Tomography (PET) imaging. We employ Independent Component Analysis (ICA) to identify shared latent patterns across controls and individuals...
2.
Babiloni C, Arakaki X, Baez S, Barry R, Benussi A, Blinowska K, et al.
Clin Neurophysiol
. 2025 Feb;
172:33-50.
PMID: 39978053
In this "centenary" paper, an expert panel revisited Hans Berger's groundbreaking discovery of human restingstate electroencephalographic (rsEEG) alpha rhythms (8-12 Hz) in 1924, his foresight of substantial clinical applications in...
3.
Italia M, Spinola A, Borroni B, DiLuca M, Gardoni F
Neurobiol Dis
. 2025 Feb;
207:106843.
PMID: 39954743
Autoantibodies targeting the GluA3 subunit of AMPA receptors (AMPARs) are implicated in various neurological disorders, including Rasmussen's encephalitis, epilepsy, and frontotemporal dementia. However, their precise role in disease pathology remains...
4.
Cotelli M, Tarantino B, Tan K, Huber H, Cantoni V, Bracca V, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e14558.
PMID: 39936177
Introduction: Modeling the survival rate in syndromes associated with frontotemporal lobar degeneration (FTLD) is essential to assess disease trajectories. Methods: In 262 patients with FTLD, we considered plasma neurofilament light...
5.
Sogorb-Esteve A, Weiner S, Simren J, Swift I, Bocchetta M, Todd E, et al.
Sci Transl Med
. 2025 Feb;
17(784):eadm9654.
PMID: 39908349
We used an untargeted mass spectrometric approach, tandem mass tag proteomics, for the identification of proteomic signatures in genetic frontotemporal dementia (FTD). A total of 238 cerebrospinal fluid (CSF) samples...
6.
Padovani A, Pilotto A, Pelucchi S, DAndrea L, Stringhi R, Gorla F, et al.
Transl Neurodegener
. 2025 Jan;
14(1):1.
PMID: 39819731
No abstract available.
7.
Bracca V, Premi E, Cotelli M, Micheli A, Altomare D, Cantoni V, et al.
Am J Geriatr Psychiatry
. 2025 Jan;
33(4):450-462.
PMID: 39799044
Objectives: The present study aims to assess the prevalence, associated clinical symptoms, longitudinal changes, and imaging correlates of Loss of Insight (LOI), which is still unexplored in syndromes associated with...
8.
Benussi A, Huber H, Tan K, Cantoni V, Rivolta J, Cotelli M, et al.
Alzheimers Dement
. 2025 Jan;
21(2):e14482.
PMID: 39776166
Introduction: Plasma-based biomarkers have shown promise for clinical implementation, but their accuracy in differentiating Alzheimer's disease (AD) from syndromes associated with frontotemporal lobar degeneration (FTLD) has yet to be fully...
9.
Abate F, Di Biasio F, Marchese R, Markushi T, Ciammola A, Ticozzi N, et al.
Parkinsonism Relat Disord
. 2024 Dec;
131():107226.
PMID: 39700727
Background: Progressive Supranuclear Palsy (PSP) is a rare, heterogeneous neurodegenerative disease for which no treatment is currently available. In the context of clinical trials, the representativeness of the included patients...
10.
Cotelli M, Draghi A, Bestetti I, Bedeschi M, Borroni B
Neurol Sci
. 2024 Dec;
PMID: 39652164
No abstract available.